| Income Statement |
| Total Revenue | 18.89B |
|
| Revenues (USD) | 2.74B |
| Cost of Revenue | 14.33B |
| Gross Profit | 4.56B |
| Operating Expenses | 3.29B |
| Research and Development Expense | 492.57M |
| Selling, General and Administrative Expense | 2.79B |
| Operating Income | 1.27B |
| Income Tax Expense | 576.65M |
| Net Income | 1.26B |
| Net Income Common Stock | 1.26B |
| Net Income Common Stock (USD) | 181.90M |
| Consolidated Income | 1.26B |
| Earnings per Basic Share | 1.14 |
| Earnings per Basic Share (USD) | 0.17 |
| Earnings per Diluted Share | 1.11 |
| Earning Before Interest & Taxes (EBIT) | 1.83B |
| Earning Before Interest & Taxes (USD) | 265.47M |
| Weighted Average Shares | 3.28B |
| Weighted Average Shares Diluted | 3.28B |
| Balance Sheet |
| Cash and Equivalents | 19.98B |
| Cash and Equivalents (USD) | 2.90B |
| Investments | 55.94B |
| Investments Current | 36.10B |
| Investments Non-Current | 19.84B |
| Trade and Non-Trade Receivables | 4.04B |
| Current Assets | 67.08B |
| Property, Plant & Equipment Net | 18.14B |
| Total Assets | 112.32B |
| Debt Current | 9.75B |
| Total Debt | 16.27B |
| Current Liabilities | 41.05B |
| Debt Non-Current | 6.52B |
| Total Liabilities | 47.89B |
| Accumulated Retained Earnings (Deficit) | 2.05B |
| Accumulated Other Comprehensive Income | 20.44M |
| Shareholders Equity | 64.37B |
| Shareholders Equity (USD) | 9.33B |
| Assets Non-Current | 45.23B |
| Total Debt (USD) | 2.36B |
| Deferred Revenue | 6.17B |
| Deposit Liabilities | 5.33B |
| Goodwill and Intangible Assets | 5.35B |
| Inventory | 2.80B |
| Liabilities Non-Current | 6.84B |
| Trade and Non-Trade Payables | 5.00B |
| Tax Liabilities | 1.21B |
| Cash Flow |
| Net Cash Flow from Financing | 502.88M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.03B |
| Net Cash Flow from Investing | 5.01B |
| Net Cash Flow from Operations | -1.47B |
| Effect of Exchange Rate Changes on Cash | -12.77M |